The relationship of serum macrophage inhibitory cytokine - 1 levels with gray matter volumes in community-dwelling older individuals

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Jiang, Jiyang ^a   Wen, Wei ^a,b   Brown, David A ^c   Crawford, John ^a   Thalamuthu, Anbupalam ^a   Smith, Evelyn ^a   Breit, Samuel N ^c   Liu, Tao ^d   Zhu, Wanlin ^e   Brodaty, Henry ^a,b   Baune, Bernhard T ^f   Trollor, Julian N ^a,c   Sachdev, Perminder S ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d BEIHANG UNIVERSITY   (China)

^e BEIJING NORMAL UNIVERSITY   (China)

^f UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 6;

AGE; AGED; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN SIZE; COGNITION; COMMUNITY LIVING; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; TEMPORAL LOBE; THALAMUS; BLOOD; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GRAY MATTER; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84929993863     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123399     Document Type: Article

References (62)

1. Meraz-Rios MA, Toral-Rios D, Franco-Bocanegra D, Villeda-Hernandez J, Campos-Pena V. Inflammatory process in Alzheimer's Disease. Frontiers in integrative neuroscience. 2013; 7:59. doi: 10.3389/fnint.2013.00059 PMID: 23964211 PubMed Central PMCID: PMC3741576.
2. Muller N, Myint AM, Schwarz MJ. Inflammation in schizophrenia. Advances in protein chemistry and structural biology. 2012; 88:49-68. doi: 10.1016/B978-0-12-398314-5.00003-9 PMID: 22814706.
3. Hamdani N, Doukhan R, Kurtlucan O, Tamouza R, Leboyer M. Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications. Current psychiatry reports. 2013; 15(9):387. doi: 10.1007/s11920-013-0387-y PMID: 23955004.
4. Krishnadas R, Cavanagh J. Depression: an inflammatory illness? Journal of neurology, neurosurgery, and psychiatry. 2012; 83(5):495-502. doi: 10.1136/jnnp-2011-301779 PMID: 22423117.
5. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999; 138(5):S419-S20. doi: 10.1016/S0002-8703(99)70266-8 PMID: 000083507500002.
6. Di Napoli M. Early inflammatory response in ischemic stroke. Thrombosis research. 2001; 103(3): 261-4.PMID: 11680414.
7. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. Journal of neuroimmunology. 2007; 184(1-2):53-68. doi: 10.1016/j.jneuroim.2006.11.014 PMID: 17188755; PubMed Central PMCID: PMC1868538.
8. Baune BT, Ponath G, Rothermundt M, Roesler A, Berger K. Association Between Cytokines and Cerebral MRI Changes in the Aging Brain. J Geriatr Psych Neur. 2009; 22(1):23-34. doi: 10.1177/0891988708328216 PMID: 000263475400003.
9. Baune BT, Konrad C, Grotegerd D, Suslow T, Birosova E, Ohrmann P, et al. Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain. Journal of neuroinflammation. 2012; 9:125. doi: 10.1186/1742-2094-9-125 PMID: 22695063; PubMed Central PMCID: PMC3464888.
10. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biological psychiatry. 2008; 64(6):484-90. doi: 10.1016/j.biopsych.2008.04.016 PMID: 18514163; PubMed Central PMCID: PMC2562462.
11. Willette AA, Coe CL, Birdsill AC, Bendlin BB, Colman RJ, Alexander AL, et al. Interleukin-8 and interleukin-10, brain volume and microstructure, and the influence of calorie restriction in old rhesus macaques. Age. 2013. doi: 10.1007/s11357-013-9518-y PMID: 23463321.
12. Jefferson AL, Massaro JM, Wolf PA, Seshadri S, Au R, Vasan RS, et al. Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology. 2007; 68(13):1032-8. doi: 10.1212/01.wnl.0000257815.20548.df PMID: 17389308; PubMed Central PMCID: PMC2758770.
13. Kesler S, Janelsins M, Koovakkattu D, Palesh O, Mustian K, Morrow G, et al. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behavior and Immunity. 2013; 30: S109-S16. doi: 10.1016/j.bbi.2012.05.017 PMID: 000316510800013.
14. Taki Y, Thyreau B, Kinomura S, Sato K, Goto R, Wu K, et al. Correlation between high-sensitivity C-reactive protein and brain gray matter volume in healthy elderly subjects. Human brain mapping. 2012. doi: 10.1002/hbm.22073 PMID: 22438310.
15. Wersching H, Duning T, Lohmann H, Mohammadi S, Stehling C, Fobker M, et al. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology. 2010; 74(13): 1022-9. doi: 10.1212/Wnl.0b013e3181d7b45b PMID: 000276255500005.
16. Fuchs T, Trollor JN, Crawford J, Brown D, Baune BT, Samaras K, et al. Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline-the Sydney Memory and Ageing Study. Aging cell. 2013. doi: 10.1111/acel.12116 PMID: 23758647.
17. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proceedings of the National Academy of Sciences of the United States of America. 1997; 94(21):11514-9.PMID: 9326641; PubMed Central PMCID: PMC23523.
18. Breit SN, Johnen H, Cook AD, Tsai VW, Mohammad MG, Kuffner T, et al. The TGF-beta superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth factors. 2011; 29(5):187-95. doi: 10.3109/08977194.2011.607137 PMID: 21831009.
19. Fairlie WD, Moore AG, Bauskin AR, Russell PK, Zhang HP, Breit SN. MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukocyte Biol. 1999; 65(1):2-5. PMID: 000077950400002.
20. Strelau J, Sullivan A, Bottner M, Lingor P, Falkenstein E, Suter-Crazzolara C, et al. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2000; 20(23):8597-603. PMID: 11102463.
21. Schober A, Bottner M, Strelau J, Kinscherf R, Bonaterra GA, Barth M, et al. Expression of growth differentiation factor-15/ macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J Comp Neurol. 2001; 439(1):32-45. doi: 10.1002/cne.1333 PMID: 11579380.
22. Brown DA, Lindmark F, Stattin P, Balter K, Adami HO, Zheng SL, et al. Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer. Clin Cancer Res. 2009; 15(21):6658-64. doi: 10.1158/1078-0432.Ccr-08-3126 PMID: 000271300200023.
23. Brown DA, Stephan C, Ward RL, Law M, Hunter M, Bauskin AR, et al. Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis. Clin Cancer Res. 2006; 12(1):89-96. doi: 10.1158/1078-0432.CCR-05-1331 PMID: 16397029.
24. Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ, et al. MIC-1 serum level and genotype: Associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res. 2003; 9(7): 2642-50. PMID: 000184108700035.
25. Brown DA, Moore J, Johnen H, Smeets TJ, Bauskin AR, Kuffner T, et al. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum. 2007; 56(3):753-64. doi: 10.1002/art.22410 PMID: 17328047.
26. Alberti C, Pinciroli P, Valeri B, Ferri R, Ditto A, Umezawa K, et al. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer. Oncogene. 2012; 31(37):4139-49. doi: 10.1038/Onc.2011.572 PMID: 000308688900006.
27. Profita M, Bonanno A, Siena L, Ferraro M, Montalbano AM, Pompeo F, et al. Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NF kappa B/ERK-dependent mechanism. European journal of pharmacology. 2008; 582(1-3):145-53. doi: 10.1016/j.ejphar.2007.12.029 PMID: 000253877700019.
28. Baek SJ, Wilson LC, Eling TE. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis. 2002; 23(3): 425-34. doi: 10.1093/carcin/23.3.425 PMID: 000174710400007.
29. Kannan K, Amariglio N, Rechavi G, Givol D. Profile of gene expression regulated by induced p53: connection to the TGF-beta family. Febs Lett. 2000; 470(1):77-82. doi: 10.1016/S0014-5793(00)01291-6 PMID: 000086001800016.
30. Baek SJ, Kim JS, Moore SM, Lee SH, Martinez J, Eling TE. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol. 2005; 67(2):356-64. doi: 10.1124/mol.104.005108 PMID: 000226412900002.
31. Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, Liu T, et al. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet. 2002; 359(9324):2159-63. doi: 10.1016/S0140-6736(02)09093-1 PMID: 12090982.
32. Johnen H, Kuffner T, Brown DA, Wu BJ, Stocker R, Breit SN. Increased expression of the TGF-b superfamily cytokine MIC-1/GDF15 protects ApoE(-/-) mice from the development of atherosclerosis. Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology. 2012; 21(6): 499-505. doi: 10.1016/j.carpath.2012.02.003 PMID: 22386250.
33. Shnaper S, Desbaillets I, Brown DA, Murat A, Migliavacca E, Schluep M, et al. Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome. International Journal of Cancer. 2009; 125(11):2624-30. doi: 10.1002/Ijc.24639 PMID: 000271516500017.
34. Jiang J, Sachdev P, Lipnicki DM, Zhang H, Liu T, Zhu W, et al. A longitudinal study of brain atrophy over two years in community-dwelling older individuals. NeuroImage. 2014; 86:203-11. doi: 10.1016/j.neuroimage.2013.08.022 PMID: 23959201.
35. Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, et al. One-Year Brain Atrophy Evident in Healthy Aging. Journal of Neuroscience. 2009; 29(48):15223-31. doi: 10.1523/Jneurosci.3252-09.2009 PMID: 000272361700023.
36. Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D, Williamson A, et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cerebral cortex. 2005; 15(11):1676-89. Epub 2005/02/11. doi: 10.1093/cercor/bhi044 PMID: 15703252.
37. Walhovd KB, Fjell AM, Reinvang I, Lundervold A, Dale AM, Eilertsen DE, et al. Effects of age on volumes of cortex, white matter and subcortical structures. Neurobiol Aging. 2005; 26(9):1261-70. doi: 10.1016/j.neurobiolaging.2005.05.020 PMID: 000232624100003.
38. Resnick SM, Goldszal AF, Davatzikos C, Golski S, Kraut MA, Metter EJ, et al. One-year age changes in MRI brain volumes in older adults. Cerebral cortex. 2000; 10(5):464-72. Epub 2000/06/10. PMID: 10847596.
39. Sachdev PS, Brodaty H, Reppermund S, Kochan NA, Trollor JN, Draper B, et al. The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. International psychogeriatrics / IPA. 2010; 22(8):1248-64. doi: 10.1017/S1041610210001067 PMID: 20637138.
40. Brown DA, Bauskin AR, Fairlie WD, Smith MD, Liu T, Xu N, et al. Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. Biotechniques. 2002; 33(1):118-+. PMID: 000176966000015.
41. Fischl B. FreeSurfer. NeuroImage. 2012; 62(2):774-81. doi: 10.1016/j.neuroimage.2012.01.021 PMID: 22248573; PubMed Central PMCID: PMC3685476.
42. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. Fsl. NeuroImage. 2012; 62(2): 782-90. doi: 10.1016/j.neuroimage.2011.09.015 PMID: 21979382.
43. Morey RA, Petty CM, Xu Y, Hayes JP, Wagner HR, Lewis DV 2nd, et al. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes. NeuroImage. 2009; 45(3):855-66. doi: 10.1016/j.neuroimage.2008.12.033 PMID: 19162198; PubMed Central PMCID: PMC2714773.
44. Ashburner J. Computational anatomy with the SPM software. Magnetic resonance imaging. 2009; 27(8):1163-74. doi: 10.1016/j.mri.2009.01.006 PMID: 19249168.
45. Patenaude B, Smith SM, Kennedy DN, Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. NeuroImage. 2011; 56(3):907-22. doi: 10.1016/j.neuroimage.2011.02.046 PMID: 000290649300007.
46. Wechsler D. Wechsler Adult Intelligence Scale-III. San Antonio: The Psychological Corporation; 1997. 47.
47. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 3rd ed. New York: Oxford University Press; 2006. PMID: 17067774
48. Wechsler D. Wechsler Memory Scale. Third edition manual. San Antonio: The Psychological Corporation; 1997.
49. Benton AL, Sivan AB, Spreen O. Der Benton Test. 7th ed. Bern: Huber; 1996.
50. Kaplan E. The Boston Naming Test. Philadelphia: Lippincott Williams Wilkins; 2001.
51. Wechsler D. WAIS-R manual. New York: The Psychological Corporation; 1981.
52. Breit SN, Carrero JJ, Tsai VW, Yagoutifam N, Luo W, Kuffner T, et al. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2012; 27(1):70-5. doi: 10.1093/ndt/gfr575 PMID: 21940482.
53. Wiklund FE, Bennet AM, Magnusson PK, Eriksson UK, Lindmark F, Wu L, et al. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging cell. 2010; 9(6):1057-64. doi: 10.1111/j.1474-9726.2010.00629.x PMID: 20854422.
54. Lindahl B. The Story of Growth Differentiation Factor 15: Another Piece of the Puzzle. Clinical chemistry. 2013. doi: 10.1373/clinchem.2013.212811 PMID: 24003064.
55. Subramaniam S, Strelau J, Unsicker K. Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways. Journal of Biological Chemistry. 2003; 278(11):8904-12. doi: 10.1074/jbc.M210037200 PMID: 000181524000007.
56. Kim KS, Baek SJ, Flake GP, Loftin CD, Calvo BF, Eling TE. Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology. 2002; 122(5):1388-98. doi: 10.1053/gast.2002.32972 PMID: 000175305500024.
57. Huh SJ, Chung CY, Sharma A, Robertson GP. Macrophage inhibitory cytokine-1 regulates melanoma vascular development. The American journal of pathology. 2010; 176(6):2948-57. doi: 10.2353/ajpath.2010.090963 PMID: 20431030; PubMed Central PMCID: PMC2877855.
58. Ferrari N, Pfeffer U, Dell'Eva R, Ambrosini C, Noonan DM, Albini A. The transforming growth factorbeta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl) retinamide. Clin Cancer Res. 2005; 11(12): 4610-9. doi: 10.1158/1078-0432.Ccr-04-2210 PMID: 000229725900042.
59. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest. 2000; 117(4):1162-72. PMID: 10767254.
60. Reyes TM, Fabry Z, Coe CL. Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli. Brain Res. 1999; 851(1-2):215-20. PMID: 10642846.
61. de Jager SCA, Bermudez B, Bot I, Koenen RR, Bot M, Kavelaars A, et al. Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. J Exp Med. 2011; 208(2):217-25. doi: 10.1084/Jem.20100370 PMID: 000287366300001.
62. Brown DA, Hance KW, Rogers CJ, Sansbury LB, Albert PS, Murphy G, et al. Serum Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15): A Potential Screening Tool for the Prevention of Colon Cancer? Cancer Epidem Biomar. 2012; 21(2):337-46. doi: 10.1158/1055-9965.Epi-11-0786 PMID: 000300073300012.